US 11,717,681 B2
Systems and methods for treating gastroesophageal reflux disease
Virender K. Sharma, Paradise Valley, AZ (US); and Shai Policker, Tenafly, NJ (US)
Filed by EndoStim, Inc., Dallas, TX (US)
Filed on Aug. 21, 2019, as Appl. No. 16/547,216.
Application 16/547,216 is a continuation of application No. 16/041,426, filed on Jul. 20, 2018, granted, now 10,420,934.
Application 16/041,426 is a continuation of application No. 15/170,462, filed on Jun. 1, 2016, granted, now 10,058,703, issued on Aug. 28, 2018.
Application 15/170,462 is a continuation of application No. 14/337,006, filed on Jul. 21, 2014, granted, now 9,381,344, issued on Jul. 5, 2016.
Application 14/337,006 is a continuation of application No. 13/447,168, filed on Apr. 14, 2012, granted, now 8,831,729, issued on Sep. 9, 2014.
Application 13/447,168 is a continuation in part of application No. 13/041,063, filed on Mar. 4, 2011, granted, now 8,712,529, issued on Apr. 29, 2014.
Claims priority of provisional application 61/475,368, filed on Apr. 14, 2011.
Claims priority of provisional application 61/444,849, filed on Feb. 21, 2011.
Claims priority of provisional application 61/422,967, filed on Dec. 14, 2010.
Claims priority of provisional application 61/414,378, filed on Nov. 16, 2010.
Claims priority of provisional application 61/384,105, filed on Sep. 17, 2010.
Claims priority of provisional application 61/371,146, filed on Aug. 5, 2010.
Claims priority of provisional application 61/328,702, filed on Apr. 28, 2010.
Claims priority of provisional application 61/318,843, filed on Mar. 30, 2010.
Claims priority of provisional application 61/310,755, filed on Mar. 5, 2010.
Prior Publication US 2022/0054833 A1, Feb. 24, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/372 (2006.01); G16H 15/00 (2018.01); G16Z 99/00 (2019.01); A61N 1/00 (2006.01); A61N 1/05 (2006.01); A61B 17/34 (2006.01); A61N 1/378 (2006.01); G16H 20/60 (2018.01); G16H 30/20 (2018.01); G16H 20/40 (2018.01)
CPC A61N 1/36007 (2013.01) [A61B 17/3468 (2013.01); A61B 17/3478 (2013.01); A61N 1/00 (2013.01); A61N 1/0517 (2013.01); A61N 1/3787 (2013.01); A61N 1/37205 (2013.01); A61N 1/37282 (2013.01); G16H 15/00 (2018.01); G16Z 99/00 (2019.02); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 30/20 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A system for treating a gastrointestinal condition of a patient, comprising:
at least one electrode adapted to be implanted such that said electrode is configured to be in electrical communication with a lower esophageal sphincter (LES) of the patient to deliver a pulse stream in accordance with a plurality of stimulation parameters;
a pulse generator in electrical communication with the at least one electrode; and
a non-volatile memory for storing programmatic code which, when executed by a processor, causes the pulse generator to generate the pulse stream in accordance with the plurality of stimulation parameters, wherein the plurality of stimulation parameters comprises a pulse amplitude having a range of 1 to 30 mAmp, wherein a value for the pulse amplitude is defined such that swallowing of the patient is not hindered while the pulse stream is being delivered to the patient.